Dismantling health stigma in ’26 – examining the role for pharma
PharmaTimes Magazine
PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.
Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.
You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.
Magazine highlights
April 2026
This month’s edition reimagines the NHS dichotomy as a dystopian game of Tetris – we investigate which parties might finally shake things up. We explore the GLP-1 explosion and how its boom will mold the medicines of the future. Plus, deep dives into AI in pharma, reproductive health in 2026, life sciences’ greatest hits, and the global impact of Trump’s healthcare decisions. Finally, comms guru Jess ‘Pharmery’ Farmery sparkles in her highly anticipated debut.
In therapies
Ten exciting new pharmaceutical drugs emerging in 2026
Happy talk…
The Briefing Room – what next for healthcare communications?
The long goodbye
Can the problem of late hospital patient discharge be solved?
Heavy headlines
Could GLP-1 obesity drugs break pharma’s safety infrastructure?
One direction
Unlocking next chapter – why the latest investment fund matters
The man machine
AI is creating a new market where the super employee is king
